A new NDA was submitted in January 2024, which the FDA did accept, and that was later converted into a priority review. An ...

Alvotech and UK-based Advanz Pharma sign agreement to commercialise three additional biosimilar candidates in Europe.

Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...

Astellas Pharma has signed an exclusive licensing agreement with Evopoint Biosciences for XNW27011, a CLDN18.2-targeting ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

In the race to decarbonize the global economy, advanced materials are no longer a luxury – they’re a necessity.

The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids ...

Eton Pharmaceuticals’ NDA for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA ...

Phase III progression-free survival data were positive for first-line Braftovi in first-line combination therapy for mCRC.

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.